Advertisement

Supply Chain



National and global factors like the Russia-Ukraine war are complicating supply chain issues in the U.S., with health systems expecting to see price hikes in certain medical supplies for which raw materials are sourced in Russia. 

The U.S. is halting distribution of sotrovimab, a COVID-19 antibody made by GlaxoSmithKline and Vir Biotechnology, in regions where the omicron subvariant BA.2 has become dominant in response to data suggesting the treatment is ineffective against the strain. 

Advertisement

Most Read

Advertisement
Advertisement